XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain/(Loss)
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2022 24,722,974        
Beginning balance, value at Dec. 31, 2022 $ 2 $ 215,110 $ (466) $ (87,903) $ 126,743
Unrealized gain on investments     265   265
Issuance of common stock upon exercise of stock options   223     223
Issuance of common stock upon exercise of stock options (in shares) 93,966        
Stock based compensation   2,384     2,384
Net loss       (16,520) (16,520)
Ending balance, shares at Mar. 31, 2023 24,816,940        
Ending balance, value at Mar. 31, 2023 $ 2 217,717 (201) (104,423) 113,095
Beginning balance, shares at Dec. 31, 2023 27,762,703        
Beginning balance, value at Dec. 31, 2023 $ 3 272,640 237 (163,424) 109,456
Unrealized loss on investments     (270)   (270)
Issuance of common stock upon exercise of stock options   704     $ 704
Issuance of common stock upon exercise of stock options (in shares) 133,282       133,282
Vesting of restricted stock units, shares 2,776        
Stock based compensation   4,200     $ 4,200
Net loss       (23,186) (23,186)
Ending balance, shares at Mar. 31, 2024 27,898,761        
Ending balance, value at Mar. 31, 2024 $ 3 $ 277,544 $ (33) $ (186,610) $ 90,904